Skip to main content

Table 4 Changes in radiological diagnosis and confidence after CE-MRI/MRAa

From: Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study

 

Total (N = 2118)

Clariscan (n = 1513)

Dotarem (n = 356)

Gadovist (n = 237)

Changes in radiological diagnosis, n (%)

 Yes

1566 (73.9)

1071 (70.8)

296 (83.1)

195 (82.3)

 No

552 (26.1)

442 (29.2)

60 (16.9)

42 (17.7)

Increased confidence in diagnosis, n (%)

 Yes

2037 (96.2)

1453 (96.0)

344 (96.6)

230 (97.0)

 No

81 (3.8)

60 (4.0)

12 (3.4)

7 (3.0)

 Confidence before CE-MR (0–100), mean (SD)

51.1 (23.7)

54.5 (23.3)

42.6 (23.7)

42.0 (19.8)

 Confidence after CE-MR (0–100), mean (SD)

87.6 (12.6)

87.7 (13.2)

87.5 (9.9)

86.6 (12.2)

  1. CE contrast-enhanced, MR magnetic resonance, MRA magnetic resonance angiography, MRI magnetic resonance imaging, SD standard deviation
  2. aData for ProHance are not shown separately owing to the low number of patients (n = 12 [0.6%])